Kavthekar Atul 4

What Happened Atul Kavthekar, Chief Financial Officer of LifeMD, Inc. (LFMD), received a grant of 337,500 restricted stock units (RSUs) reported on a Form 4 covering the May 11, 2026 award. The award is reported at $0.00 per share (no cash paid) and is an equity compensation grant rather than an open-market purchase or sale.

Key Details

• Transaction date: May 11, 2026; Form 4 filed May 13, 2026 (appears timely — within the typical two-business-day filing window).
• Transaction type/code: Award/Grant (A). Shares granted: 337,500; reported price: $0.00.
• Vesting (footnote F1): 112,500 RSUs vest on March 16, 2027; 112,500 on March 16, 2028; remaining 112,500 on March 16, 2029.
• Shares owned after transaction: not specified in the provided filing excerpt.
• No indication in the filing that shares were sold or that this was a 10b5-1 plan or tax-withholding event.

Context RSUs are conditional awards that typically convert into shares only as they vest and may be forfeited if the executive leaves before vesting. Grants like this are common executive compensation and do not by themselves indicate buying or selling intent; purchases are generally a stronger signal of insider conviction.